Results per Page:
Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)
The HIV Vaccine Trials Network (HVTN), the NIH/NIAID Division of AIDS (DAIDS), and Janssen Vaccines and Prevention are pleased to welcome scientific study proposals involving specimens and/or study data from the Imbokodo (HVTN 705/VAC89220HPX2008) HIV vaccine clinical trial.
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future
Harmonized approach and vast database of trial participants could bolster future research well beyond SARS-CoV-2
Newly defined biomarker may accelerate clinical trials for vaccines to prevent HIV-1 infection
A study published in the Aug. 22, 2022 issue of Nature Medicine identifies a new biomarker that appears effective as a surrogate endpoint to reliably predict the ability of broadly neutralizing monoclonal antibodies to prevent acquisition of HIV-1, the most common type of the virus that causes AIDS.
CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2
Response comparable to mRNA vaccines and if authorized, could help bolster global vaccine supplies
HVTN Launches First of Its Kind Volunteer Registry
Red Ribbon Registry Opens to Volunteers for HIV Vaccine Studies